A detailed history of Virtus Investment Advisers, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 13,662 shares of HAE stock, worth $1.15 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
13,662
Previous 13,662 -0.0%
Holding current value
$1.15 Million
Previous $1.17 Million 0.17%
% of portfolio
0.88%
Previous 0.91%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$72.75 - $90.6 $563,521 - $701,787
7,746 Added 130.93%
13,662 $1.13 Million
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $374,482 - $465,352
5,916 New
5,916 $438,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.32B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Virtus Investment Advisers, Inc. Portfolio

Follow Virtus Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.